Beyond Net Income Per Share from 2010 to 2026
| DOCKF Stock | USD 0.17 0.01 6.25% |
Net Loss | First Reported 2010-12-31 | Previous Quarter (0.000032) | Current Value (0.000034) | Quarterly Volatility 6.3 K |
Check Beyond Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Beyond Medical's main balance sheet or income statement drivers, such as Discontinued Operations of 122.5 K, Interest Expense of 7.9 K or Interest Income of 6 K, as well as many indicators such as Price To Sales Ratio of 3.49, Dividend Yield of 0.0 or Days Sales Outstanding of 11.75. Beyond financial statements analysis is a perfect complement when working with Beyond Medical Valuation or Volatility modules.
Beyond | Net Income Per Share | Build AI portfolio with Beyond Stock |
The Net Income Per Share trend for Beyond Medical Technologies offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Beyond Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Beyond Medical's Net Income Per Share Growth Pattern
Below is the plot of the Net Income Per Share of Beyond Medical Technologies over the last few years. It is Beyond Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Beyond Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Income Per Share | 10 Years Trend |
|
Net Income Per Share |
| Timeline |
Beyond Net Income Per Share Regression Statistics
| Arithmetic Mean | (2,851) | |
| Coefficient Of Variation | (222.14) | |
| Mean Deviation | 4,606 | |
| Median | (2.01) | |
| Standard Deviation | 6,334 | |
| Sample Variance | 40.1M | |
| Range | 19.6K | |
| R-Value | 0.54 | |
| Mean Square Error | 30.5M | |
| R-Squared | 0.29 | |
| Significance | 0.03 | |
| Slope | 671.32 | |
| Total Sum of Squares | 641.9M |
Beyond Net Income Per Share History
About Beyond Medical Financial Statements
Beyond Medical stakeholders use historical fundamental indicators, such as Beyond Medical's Net Income Per Share, to determine how well the company is positioned to perform in the future. Although Beyond Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Beyond Medical's assets and liabilities are reflected in the revenues and expenses on Beyond Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Beyond Medical Technologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Beyond Medical Correlation against competitors. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Can Industrial Machinery & Supplies & Components industry sustain growth momentum? Does Beyond have expansion opportunities? Factors like these will boost the valuation of Beyond Medical. Projected growth potential of Beyond fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Beyond Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (0.07) | Revenue Per Share | Quarterly Revenue Growth (0.92) | Return On Assets | Return On Equity |
Investors evaluate Beyond Medical Techn using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Beyond Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Beyond Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Beyond Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Beyond Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Beyond Medical's market price signifies the transaction level at which participants voluntarily complete trades.